Ekaterine Alexandris

Ekaterine Alexandris currently serves as the Sr. Director and Asset Leader for Clinical Science in Oncology at Daiichi Sankyo, Inc., a position held since April 2020. Prior experience includes roles as Director and Principal Clinical Research Scientist in Hematology at Celgene from July 2017 to April 2020, and as Director and Principal Clinical Research Scientist in Oncology at Eli Lilly and Company from 2011 to July 2017. Ekaterine's career also includes serving as Expert Clinical Manager at Novartis from 2006 to 2011 and as Senior Clinical Research Associate at BD from 2004 to 2006. Academic credentials include degrees from Cornell University and Albany Medical College.